Prognosis and Targeted Therapy Related Molecular Screening Program for Patients of Breast Cancer in China
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: OTHER: detect gene mutations of ctDNA and ctRNA
Sponsor: Peking University Cancer Hospital & Institute
Collaborators: Predicine (Shanghai) Medical Technology Co., Ltd.